Kathleen Scott

Kathleen D.
Scott currently works at YMCA of San Diego County, as Chairman, Dermata Therapeutics, Inc., as Independent Director from 2021, Hale BioPharma Ventures LLC, as Managing Director, NKGen Operating Biotech, Inc., as Independent Director, NKGen Biotech, Inc., as Independent Director from 2023, ARS Pharmaceuticals Operations, Inc., as Chief Financial Officer from 2022, and ARS Pharmaceuticals, Inc., as Chief Financial Officer from 2022.
Ms. Scott also formerly worked at BioSurplus, Inc., as Chief Financial Officer & Director from 2012 to 2014, Corporate Directors Forum, as Director from 2012 to 2024, Conatus Pharmaceuticals, Inc., as Independent Director from 2019 to 2020, Recros Medica, Inc., as Chief Financial Officer from 2014 to 2021, MDRejuvena, Inc., as Chief Financial Officer from 2014 to 2016, RA Capital Associates LLC, as Partner from 1994 to 2010, The Phi Beta Kappa Society, as Member, FeRx, Inc., as Chief Financial Officer, Zerigo Health, Inc., as Chief Financial Officer from 2014 to 2016, Adigica Health, Inc., as Chief Financial Officer from 2016 to 2021, Neurana Pharmaceuticals, Inc., as Chief Financial Officer from 2017 to 2022, Oncternal Therapeutics, Inc., as Chief Financial Officer in 2016, and Arthur Andersen LLP, as Auditor from 1991 to 1994.
Ms. Scott received her undergraduate degree from the University of California, Los Angeles.